I . Hepatic fatty acid synthesis, measured in vivo using 8H,0, was increased by a single dose of L-tryptophan (50 mg/kg body-weight) to both fed and fasted rats and by a supplement of tryptophan to the diet (2.5 g/kg diet for 7 d) when the rats were killed midway through the feeding period.
L-Tryptophan has a number of metabolic effects besides its role as rate-limiting amino acid in protein synthesis and polysome function. For example, several groups of workers have commented on the hypoglycaemic activity of large doses of tryptophan to fasted rats (McDaniel et al. 1973 ; Smith & Pogson, 1977 ) and a single dose of the amino acid is known to stimulate hepatic fatty acid synthesis in both fasted (Sakurai et al. 1974 ) and fed rats (Miyazawa et al. 1975) . However, an enhancement of lipogenesis in rats seems inconsistent with the observed hypotriglyceridaemic activity for tryptophan in human nephrotic hyperlipidaemia (Schapel et al. 1974 ) although the metabolic states are, of course, very different. It was the purpose of the present experiments to investigate in more detail some of the effects of relatively moderate supplements of tryptophan on intermediary metabolism in the rat under physiological conditions. In particular, we have attempted to reconcile the various effects of tryptophan on triglyceride and fatty acid (FA) metabolism and to determine the relative importance of the effects on lipid and carbohydrate levels.
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rats/cage) so that the mean body-weight of each group was the same. Where applicable, body-weight was recorded throughout the experimental period.
Biological measurements. The synthesis of FA in liver and small intestine, in vivo, was measured by the method of Fears & Morgan (1976). FA synthesis in fat pads, in vivo, was measured by procedures similar to those used for the other tissues. The incorporation of radioactivity from DL-[benzene ring U-14C]tryptophan into FA was determined by procedures similar to those described for the incorporation of 3H,0. The incorporation of radioactivity into protein was determined by the method of Mans & Novelli (1961). For the measurement of radioactivity as tryptophan, and metabolites other than lipid and protein, I vol. tissue homogenate (zoo g/1 0.16 M saline (9 g sodium chloride/l)) was mixed with 2 vol. 0.6 ~-trichloroacetic acid and the precipitate was washed with 2 vol. 0.6 M-trichloroacetic acid. The supernatant fractions were combined and extracted three times with 5 vol. diethyl ether. Radioactivity in the aqueous phase was measured. Total triacylglycerol (TG) (1965) . Total FFA in the liver was measured using a similar method on the chloroform phase of total lipid extract. Liver glycogen was measured by the method of Montgomery (1957). Blood glucose was measured by the method of Trinder (1969). For the determination of erythrocyte enzyme activities, red cells were separated from whole blood and washed with I vol. saline. The cells were haemolysed by the addition of 2 vol. distilled H,O and then freezing. The activities of L-alanine aminotransferase (EC 2 . 6 . I .2) and L-aspartate aminotransferase (EC 2 . 6 . I . I) were determined using Boehringer Mannheim test combinations (The Boehringer Corporation (London) Ltd, Uxbridge Road, London W5 2TZ). The oxidation of [~J~CIpalmitic acid was measured by the method of Ontko & Jackson (1964) using a liver homogenate I 00 g/l 0.25 mM-sucrose--I mM-EDTA. Serum chylomicrons, very-low-density and low-density lipoproteins wcre precipitated using 0.066 M-manganese chloride and heparin (200 U.S.P. units/ml) (Burstein & Scholnick, 1973) . The concentration of TG in the chloroform phase of the total lipid extract of the precipitate was measured using an AutoAnalyzer.
Statistical analysis. Statistical analyses were done using Student's t test.
RESULTS
Acute eflects of a single dose of trypotphan The lipogenic response to a single dose of L-tryptophan, calculated to be approximately equivalent to 20' ); of the normal daily intake, was similar in rats fed ad lib. and in rats fasted for 24 h before dosing ( Table I ). The synthesis of FA, 2 h after the intraperitoneal dose of tryptophan, was increased without any change in the concentration of liver TG. Serum TG were slightly increased in concentration. As expected, both hepatic FA synthesis and the concentration of serum triglyceride were higher in fed than in fasted rats.
The stimulatory effect on FA synthesis in vivo is in contrast to the inhibitory effect observed in vitro. Tryptophan and its metabolites, kynurenic and xanthurenic acids, reduced [~-'*C]acetate incorporation into FA in liver slices taken from rats maintained on the control diet for at least 2 weeks. At 0.5 mM lipogenesis in vitro was inhibited by 76, 72 and 75 yo respectively.
In the fasted rats, the concentration of liver glycogen, already low, was markedly reduced Significantly different from corresponding control value: *P < 001, ** P < 0001.
-f Fatty acid synthesized (pg/h per g tissue), measured by incorporation of *H from 9H,0.
by tryptophan (Table I ) but a small decrease in blood glucose was not statistically significant. There was no change in the FFA concentration in serum or liver.
Effects of supplementary dietary tryptophan
To determine whether the acute stimulatory effect of tryptophan on lipogenesis was maintained when additional tryptophan was included in the diet, rats were fed for 7 d on a stock diet supplemented so as to give approximately twice the control intake of tyrptophan. Under these conditions, tryptophan did not influence the body-weight gain or the food intake. The response to additional tryptophan depended on the time of day when the rats were killed ( Table 2 ) . At midnight, that is during the feeding period when lipogenesis is maximal, but not at midday, tryptophan increased FA synthesis in the liver but not at other important body sites, for example, ileum and epididymal adipose tissue. We found no effect of dietary supplements (2.5 g/kg) of two other amino acids: DL-alanine and L-lysine hydrochloride on hepatic lipogenesis.
The concentration of serum TG was significantly reduced by tryptophan, whether the rats were killed at midday or midnight, there was no effect on the concentration of T G or glycogen in the liver. The activities of the erythrocyte enzymes L-alanine aminotransferase and L-aspartate aminotransferase were measured as indices of pyridoxine status (Beaton & Cheney, 1965 ) but were not affected by the additional tryptophan.
The effect of dietary tryptophan on T G metabolism was investigated further in rats given an intraperitoneal dose of Triton WR 1339 (Chromatography Services Co., Birkenhead, Cheshire), a non-ionic detergent which inhibits the clearance of serum TG by the enzyme lipoprotein lipase (EC 3 . I . I .3) (Scanu, 1965) . As before, dietary tryptophan alone reduced serum T G with no effect on liver T G or body-weight gain ( Table 3) . As expected, Triton WR I 339 given 24 h before the end of the experiment increased both serum T G and the concentration of heparin-precipitable lipoproteins (chylomicrons, very-low-density and low-density lipoproteins). The combination of Triton WR 1339 plus dietary tryptophan induced an even greater elevation of serum TG and of the heparin-precipitable lipoproteins than did Triton WR 1339 alone, suggesting that the previous hypotriglyceridaemic activity of tryptophan was mediated by an enhancement of lipoprotein lipase activity. 1 Enzyme activities (U/1 blood). 
Metabolism of radio-labelled DL-tryptophan
Tryptophan is known to be metabolized to acetyl-CoA (Nishizuka et al. 1970) and might itself provide the substrate for an increase in FA synthesis. This possibility was examined using radio-labelled DL-tryptophan (Table 4) . At 2 h after a single intraperitoneal dose of DL-[benzene ring U-l*C]tryptophan to fed rats, radioactivity was found in the lipid fraction of liver, small intestine and adipose tissue in addition to the protein and amino acid fractions. If the assumption is made that the specific radioactivity of free tryptophan in the liver and other tissues is equivalent to the specific radioactivity in the dose then the contribution made by acetyl-CoA from tryptophan to total FA synthesis is calculated to be of the order of less than I yo. Because of the contribution made by endogenous tryptophan, the specific radioactivity in the body will be less than that in the dose. Hence the rate of lipogenesis from radiolabelled tryptophan is underestimated. However, the dose of tryptophan administered was large in relation to the total body pool of the free amino acid so it seems unlikely that tryptophan could make a significant contribution to the substrate for lipogenesis. In the first experiment with mercaptopicolinic acid, a single oral dose to fasted rats did appear to increase FA synthesis in the liver after 2 h but not in the ileum or epididymal adipose tissue (Table 5) . However, the increase in lipogenesis was insufficient to account for the large increments observed in the concentration of liver and serum TG. In a second experiment, we studied the influence of mercaptopicolinic acid on the oxidation of FFA in fasted rats. After 2 h the production of carbon dioxide and ketone bodies from [~-~TC]palmitate ex vivo was markedly inhibited with a concomitant increase in the concentration of hepatic FFA. Mercaptopicolinic acid lowered blood glucose in fasted rats in both experiments although the change was more marked in the second study.
Effects of a single dose of mercaptopicolinic acid
In contrast to the effects of tryptophan and in contrast to its effects on fasted rats, a single dose of mercaptopicolinic acid had negligible effect on carbohydrate and lipid metabolism in fed rats.
DISCUSSION
Our studies have confirmed previous observations (Sakurai et al. 1974; Miyazawa et al. 1975 ) of an enhanced rate of hepatic FA synthesis after a single dose of L-tryptophan and have noted a similar action after supplementation of the diet with tryptophan when the rats were killed during the feeding period. The observation that FA synthesis was not elevated when the rats were killed in the post-absorptive state suggests that the stimulus is of limited duration. In addition, however, in contrast to the response to a single intraperitoneal dose, supplementary dietary tryptophan reduced the concentration of serum TG, whether or not Significantly different from corresponding control value: * P < 0.05, ** P < 0.01, *** P < 0'001.
Fed :
t Fatty acid synthesized (pg/h per g tissue), measured by incorporation of *H from sHaO.
3 Free fatty acid oxidation (nmol/h per g tissue).
FA synthesis was stimulated. The reduction in serum triglyceride cannot be attributed to an impaired lipoprotein output from the liver because we observed no increase in liver lipid, although other workers have noted an effect at a much higher dose of tryptophan (Hirata et al. 1967) . The effect of the amino acid on lipid metabolism seems more general than the effect on carbohydrate metabolism, which was confined to fasted rats. The hypoglycaemic action of tryptophan, and the metabolite quinolinic acid, has been attributed to an inhibition of gluconeogenesis at phosphoenolypruvate carboxykinase (Rosen & Nichol, 1964 ; McDaniel et al. 1973) . It has been suggested ) that the tryptophan-induced increase in FA synthesis is a result infer alia of the activation of the lipogenic enzyme acetylCoA carboxylase (EC 6.4. I . 2) by citrate whose accumulation is dependent upon the intramitochondria1 concentration of oxaloacetate which increases because of the inhibition of phosphoenolpyruvate carboxykinase. In general, there is no doubt that an inverse correlation exists between the rates of gluconeogenesis and lipogenesis in a variety of metabolic states (Young et al. 1964; Sellers et al. 1974; Reed & Tarver, 1975) . In our experiments, however, an effect of tryptophan on FA synthesis was observed even when carbohydrate metabolism appeared unaffected and the lack of association between lipogenesis and gluconeogenesis is underlined by the results obtained with mercaptopicolinic acid, which was without demonstrable effect in fed rats.
Our results also exclude other possible explanations for the effect of tryptophan on FA synthesis. Although the catabolism of tryptophan does provide acetyl-CoA as substrate for lipogenesis, the flow of Cz units is too small to contribute significantly to the synthesis of lipid. Neither can the results be attributed to pyridoxine deficiency (Wittman, 1976) arising from increased utilization of pyridoxal phosphate by the tryptophan catabolic pathway. No impairment of pyridoxine status was observed and the diet used, Oxoid Breeding Diet, supplies twice the recommended intake of pyridoxine for normal rats.
The action of tryptophan in the liver might seem to be inconsistent with the serum TGlowering effect but the results from the Triton experiment suggest an additional activation of lipoprotein lipase (EC 3. I . I . 3) . The ability of tryptophan to lower serum TG might be explained by metabolism to nicotinic acid, a known hypolipidaemic agent, which is believed to increase the activity of lipoprotein lipase (Nikkila, 1971) . However, we found that nicotinic acid, at a dose of IOO mg/kg body-weight in the diet for 7 d, was not hypotriglyceridaemic. This dose was considered to provide an intake equivalent to the concentration produced endogenously from the supplementary tryptophan provided in our experiments (Harris & Kodicek, 1950) .
We consider that the explanation of our findings for tryptophan is as follows. Tryptophan stimulates insulin secretion (Floyd et al. 1966; Ajdukiewicz et al. 1968 ) and the sensitivity of rats to tryptophan is dependent on the presence of functional pancreatic /? cells (Smith & Pogson, 1977) . Insulin increases the activities of hepatic FA synthetase (Lakshmanan et al. 1972 ) and adipose tissue lipoprotein lipase (Wing et al. 1966 ). An effect by tryptophan on insulin levels has physiological relevance because tryptophan and its metabolite 5-hydroxytryptamine are known to reduce physical activity in the rat (Taylor, 1976) . As food intake was unaffected in our experiments a greater proportion of dietary energy was available for storage as carcass lipid, this process being mediated by increases in the activities of the enzymes of hepatic FA synthesis and of adipose tissue lipoprotein lipase.
Although our results have been obtained at relatively high dietary intakes of tryptophan, a more moderate intake of the amino acid may also participate in the control of intermediary metabolism. At least some of the effects noted in our rat experiments are produced by small supplements of tryptophan to man (Schapel et al. 1974) . A role in carbohydrate metabolism has been emphasized by previous workers but the present results suggest that the influence of tryptophan and its metabolites on lipid metabolism is more general and might explain a number of observations. For example, the diurnal rhythm in the rate of hepatic lipogenesis can be correlated with the diurnal variation in plasma tryptophan (Fernstrom et al. 1971) . Elevated rates of FA synthesis are found in those metabolic states characterized by an increase in tryptophan catabolism along the nicotinic acid pathway, as after oral contraceptive therapy (Horwitt et al. 1975) . Finally, the effects on lipid metabolism of agents such as clofibrate have been attributed to their actions on the metabolism of tryptophan (Sirtori et al. 1977) .
